LabCorp Backs Resolution Bioscience’s Liquid Biopsy Test for NSCLC
XTalks
SEPTEMBER 28, 2020
The liquid biopsy will therefore help personalize medicines for patients based on the molecular features of their disease. The test involves isolating circulating tumor DNA in the blood and sequencing it to look for relevant gene mutations.
105 
Let's personalize your content